Albany Molecular Research (AMRI) Director Veronica Jordan, Ph.D to Retire
Monday, April 11, 2016
Source: Street Insider
Albany Molecular Research (NASDAQ: AMRI) disclosed that on April 11, 2016, Veronica G.H. Jordan, Ph.D. informed the Board of Directors of the “Company that she will not stand for re-election when her current term expires at the Company’s 2016 Annual Meeting of Stockholders due to her intention to retire from the Board of Directors, the Compensation Committee of the Board of Directors and the Audit Committee of the Board of Directors, effective June 1, 2016, in order to devote further time and attention to her other business ventures. Dr. Jordan’s decision was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.